Next Article in Journal
Segmental Scleral Buckle: A Novel Strategy for Addressing Early Recurrent Inferior Retinal Detachment in Silicone Oil-Filled Eyes
Next Article in Special Issue
Exploring Fungal Abundance and WHO Fungal Priority Pathogens in Agricultural Fields: A One Health Perspective in Northeast Thailand
Previous Article in Journal
Applications and Effectiveness of 3D Printing in Various Ankle Surgeries: A Narrative Review
Previous Article in Special Issue
Assessing Potential Reservoir of Multidrug-Resistant Bacteria in the Oral Microbiota of Captive Burmese and Royal Pythons
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antibacterial Effects of Er:YAG Laser Irradiation on Candida–Streptococcal Biofilms

1
Faculty of Medicine and Dentistry, Wroclaw Medical University, 50-367 Wroclaw, Poland
2
Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
3
Laser Laboratory, Dental Surgery Department, Faculty of Dentistry, Wroclaw Medical University, 50-367 Wroclaw, Poland
4
Department of Periodontal Diseases and Oral Mucosa Diseases, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
5
Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
6
Department of Periodontics, School of Dentistry, Virginia Commonwealth University VCU, Richmond, VA 23298, USA
*
Author to whom correspondence should be addressed.
Life 2025, 15(3), 474; https://doi.org/10.3390/life15030474
Submission received: 21 February 2025 / Revised: 5 March 2025 / Accepted: 13 March 2025 / Published: 16 March 2025
(This article belongs to the Special Issue Trends in Microbiology 2025)

Abstract

:
In contemporary dentistry, laser-based interventions have become one of the mainstays of care for patients with oral biofilm diseases, such as candidiasis, periodontal disease and peri-implantitis. The purpose of this study was to evaluate the effectiveness of Er:YAG laser (LightWalker, Ljubljana, Fotona, Slovenia) irradiation at varying irradiance levels (T1: 11.3 W/cm2 and T2: 120.54 W/cm2) on microbial viability in single- and dual-species biofilm models, focusing on Candida albicans, Candida glabrata and Streptococcus mutans, to address challenges in managing complex oral biofilms in clinically relevant settings. The results showed substantial microbial reduction, with C. albicans being the most susceptible microorganism (93–99.9%), while C. glabrata exhibited marked resistance at higher irradiance levels. Interestingly, S. mutans demonstrated varying reductions based on the biofilm composition, highlighting the influence of microbial interactions. This study concluded that the Er:YAG laser effectively reduced biofilm viability, with its efficacy depending on the microbial composition and irradiance settings. These findings highlight the need for tailored erbium laser parameters to optimize clinical outcomes, underscoring the need for individualized polymicrobial biofilm management, particularly in periodontal and peri-implant therapies.

1. Introduction

Microorganisms often exist within complex biofilms that facilitate multiple interactions in the mouth, which may be cooperative, mutualistic, synergistic or competitive. Fungal species such as Candida albicans are commonly found alongside bacteria like Streptococcus mutans in oral biofilms, where their interactions are synergistic. Although S. mutans has long been considered the primary causative agent of dental caries, recent research indicates an increased prevalence of S. mutans that coexists with C. albicans in biofilms, enhancing their virulence especially in cariogenic biofilms, advanced oral mucosal infections or peri-implantitis [1,2,3]. Bacterial–fungal interactions have become a growing area of interest due to their strong link to oral and pharyngeal diseases. The human oral cavity hosts a variety of microorganisms, including Streptococci and the yeast Candida spp. Studies indicate that multispecies biofilms containing these organisms can be associated with several oral health issues, including denture stomatitis, tooth decay, gum disease, endodontic complications, peri-implant infections and oral cancer [3,4,5,6,7,8,9].
Effective oral biofilm management involves regular mechanical removal through brushing and professional dental cleaning. As antibiotic and antifungal resistance increases, there is a growing need to explore advanced combined therapies and techniques, with the use of antimicrobial agents, photodynamic therapy and photobiomodulation with different wavelengths of lasers for targeted biofilm disruption [10,11,12,13,14,15,16,17,18]. Erbium lasers are used for different purpose in many fields in dentistry, including endodontics, prosthodontics, orthodontics, periodontics and oral pathology management [19,20,21,22,23,24,25,26,27]. Consistent biofilm control not only preserves oral health but also reduces the risk of systemic complications linked to oral infections [28,29,30,31].
The erbium family of lasers effectively targets fungi and bacteria through its photoacoustic and photothermal effects. When the laser interacts with water within the biofilm, it induces rapid vaporization, creating micro-explosions that mechanically disrupt the biofilm structure. These photoacoustic waves generate pressure changes, fragmenting the extracellular matrix and releasing microorganisms from the biofilm [32,33,34]. This process reduces microbial load and exposes deeper biofilm layers for further treatment or immune response. The thermal energy produced by the laser additionally damages microbial cell walls, enhancing antimicrobial efficacy [35,36,37,38,39,40]. These mechanisms make the Er:YAG laser a highly effective tool for biofilm disruption, as demonstrated in studies addressing both bacterial and fungal biofilms, such as Streptococcus mutans and Candida albicans.
The purpose of this study was to evaluate the effects of an erbium: yttrium–aluminium–garnet (Er:YAG) laser at 2940 nm on planktonic single- and dual-species cultures and biofilms composed of Candida spp. and Streptococcus mutans. Additionally, this study investigated novel low-fluence laser parameters tailored for the clinical treatment of periodontitis and peri-implant inflammation, aiming to effectively target and eradicate pathogens in mixed biofilms containing Candida spp. The null hypothesis states that Er:YAG laser irradiation has no significant antifungal effect on Candida spp. biofilm, meaning it neither inhibits biofilm growth nor reduces the viability of mature biofilm, regardless of the applied low-fluence and low-irradiance laser settings.

2. Materials and Methods

2.1. Sample Preparation

This study utilized clinical microorganisms of Candida albicans, Candida glabrata and Streptococcus mutans isolated from patients diagnosed with oral candidiasis and carious lesions (Ethical Committee Approval No: KB- 429/2024). The research protocol was developed based on a previous experiment using a neodymium laser application [41].
Samples were preserved in trypticase soy broth (Biomaxima, Lublin, Poland) at −80 °C, with each maintained in duplicate. Before experimentation, the strains were grown under optimal conditions for their optimal growth:
-
Candida spp.: incubated aerobically on Sabouraud Dextrose Broth (Biomaxima, Lublin, Poland) at 37 °C for 48 h.
-
S. mutans: grown on Brain Heart Infusion (BHI) agar (Biomaxima, Lublin, Poland) at 37 °C for 48 h under an atmosphere enriched with 5% CO2.

2.2. Sample Preparation Methods

To ensure better differentiation of results, two types of sample preparations were used:
(a)
Planktonic cell solutions: Microbial suspensions were adjusted to a 0.5 McFarland density following these preparations:
-
Single-species cultures: 100 µL of microbial suspension (C. albicans, C. glabrata and S. mutans) was mixed with 900 µL of BHI broth containing 5% sucrose.
-
Mixed cultures: combination of 100 µL of each microorganism was added to 800 µL of BHI broth to create the following:
  • C. albicans + S. mutans (CASM);
  • C. glabrata + S. mutans (CGSM);
  • C. albicans + C. glabrata (CACG).
(b)
Biofilm formation
This study utilized two biofilm models: single-species and dual-species biofilms. The biofilms were cultivated in dark 96-well flat-bottom polystyrene plates (FL Medical, Equimed, Krakow, Poland) under controlled conditions.
-
Single-species biofilm: each well received 100 µL of microorganism suspension (0.5 McFarland density) (C. albicans, C. glabrata or S. mutans) along with 150 µL of BHI broth containing 5% sucrose, bringing the total well volume to 250 µL per well.
-
Dual-species biofilm: 100 µL of each different microorganism suspension (0.5 McFarland density) was mixed, along with 50 µL of BHI broth containing 5% sucrose, making a total volume of 250 µL.
The plates were incubated at 37 °C for 24 h, with aerobic conditions for Candida spp. and 5% CO2 environment for Streptococcus mutans. Biofilm formation was observed on both the bottom and walls of the wells.

2.3. Laser Application

All samples were covered with dark Eppendorf tubes (for planktonic cultures) or dark 96-well polystyrene plates (for biofilm) and irradiated using an Er:YAG dental laser handpiece (H14, LightWalker, Ljubljana, Fotona, Slovenia) equipped with a 1.3 mm diameter cylindrical sapphire tip.
To minimize laser light scattering, dark tubes and polystyrene plates were used, ensuring that non-irradiated controls remained unaffected. This setup allowed for controlled experimental conditions to ensure reliable results. The laser handpiece was positioned 10 mm above the sample surface, either over the microbial suspension (planktonic cultures) or near the well’s edge (biofilm) (Figure 1).

Experimental Groups

Two distinct laser energy settings were applied: T1 (lower power): 0.15 W, 2 Hz, 30 s and 11 W/cm2 and T2 (higher power): 1.6 W, 40 Hz, 30 s and 120 W/cm2. A control group was not exposed to laser irradiation (Table 1). All experiments were performed in 2 replications. The selection of parameters for the T2 group was based on their established use in clinical applications for periodontal pocket debridement, where higher irradiance has been shown to effectively reduce bacterial loads [37,38]. These parameters were chosen as a benchmark to evaluate their efficacy compared to significantly lower irradiance levels (T1), which were included to explore whether minimal antibacterial effects could still be achieved. This comparison aimed to determine the potential of T1 settings for applications such as peri-implantitis treatment, focusing on the decontamination of implants and surrounding bone while minimizing energy output.

2.4. Measurement of Microbial Load

2.4.1. Immediate and 24 Post-Irradiation Reduction in CFU/mL (Colony-Forming Units) (Planktonic Cultures)

Laser irradiation experiments were conducted on dark Eppendorf tubes containing single- or dual-species microbial suspensions. Immediately following irradiation, 100 µL of each sample was extracted, serially diluted in geometric progression, and 0.1 µL of the final dilution was plated onto solid BHI agar. The plates were incubated at 37 °C for 24 h under conditions matching the microbial species: aerobic incubation for Candida sp. and elevated CO2 atmosphere for Streptococcus mutans. Colony counts from the incubated plates were used to calculate CFU/mL values.
Following laser exposure, suspensions were incubated for 24 h at 37 °C. After incubation, 100 µL of each suspension was extracted, diluted serially, and 0.1 µL of the final dilution was plated onto BHI agar. These plates were incubated for another 24 h, and CFU/mL values were calculated.
The control samples were processed identically, but without laser exposure.

2.4.2. Assessment of Biomass Reduction in Biofilms (Quantitative Method—CFU/mL)

Freshly prepared single- and dual-species biofilms were used for testing. To remove non-adherent cells, wells were washed three times with 0.9% NaCl solution before laser irradiation. The biofilms were then exposed to the Er:YAG laser and immediately scraped using sterile swabs. The collected biofilm material was then agitated in 0.5% saponin solution (Sigma-Aldrich, Saint Louis, MO, USA) and vortexed for 1 min to ensure biofilm cell dispersion. A 100 µL aliquot of the resulting suspension was serially diluted in geometric progression, and 0.1 µL of the final dilution was plated onto a solid growth medium for quantitative analysis (for bacterial–fungal biofilm, it was BHI agar; for CA-CG biofilm, it was after CHROMagar Candida medium (Becton Dickinson)—growth of C. albicans colonies appearing green; growth of C. glabrata colonies appearing purple). The plates were incubated at 37 °C for 24 h, with the yeast biofilms (Candida spp.) maintained under aerobic conditions, while the Streptococcus mutans biofilms were incubated under an elevated CO2 environment. Colony counts from the incubation were used to calculate CFU/mL values.
For the control group, biofilms were prepared and processed using the same protocol but were not subjected to laser irradiation.

2.4.3. Biofilm Biomass Measurement (Crystal Violet Assay)

To assess biofilm biomass, a crystal violet assay was conducted. Fixed biofilms were air-dried for 45 min at room temperature. Next, 250 µL of 0.1% crystal violet solution (Chempur, Piekary Ślaskie, Poland) was added to each well, and plates were incubated for 20 min to allow staining. Excess violet was carefully removed, and wells were washed three times with distilled water, followed by an additional 20 min of air-drying. Biofilm biomass was quantified by dissolving the bound dye in 200 µL of 95% ethanol (Honeywell, Charlotte, NC, USA) and measuring at 540 nm using an ELISA reader (Biochrom Asys UVM 340; Biochrom Ltd., Fullerton, CA, USA).

2.5. Statistical Analysis

All statistical analyses were performed using GraphPad Prism software (version 10.0.3; GraphPad Software, San Diego, CA, USA). The Shapiro–Wilk’s test was applied to assess whether the data followed a normal distribution. Depending on the results, either parametric or non-parametric statistical tests were used for analysis. For comparisons involving multiple groups, data that met the normality criteria were analyzed using one-way ANOVA, followed by Turkey’s post hoc test. If the normality assumption was violated, the Kruskal–Wallis test was employed, with Dunn’s post hoc test for pairwise comparisons. For two-group comparisons, Student’s t-test was used when data were normally distributed, while Mann–Whitney U test was applied to non-normally distributed data. Results were reported as mean ± standard deviation (SD), and statistical significance was set at p < 0.05. Additionally, correlation analysis was performed to investigate potential association between biofilm reduction and laser energy settings, using Pearson correlation for normally distributed data and Spearman correlation for non-parametric data. All tests were carried out at 95% confidence interval (CI) to ensure reliability of the findings.

3. Results

3.1. Microbial CFU Reduction in Single-Species Planktonic Cultures

This study evaluated the reduction in colony-forming units (CFU/mL) following Er:YAG laser irradiation in single-species planktonic cultures. The most significant reduction was observed for Candida glabrata, with mean CFU/mL of 92.6% ± 4.2% at the T1 settings and 88.5% ± 4.7% at the T2 settings after 24 h.
However, for C. albicans and C. glabrata, neither laser setting (T1 vs. T2) nor the time of assessment (directly after irradiation (DAI) vs. 24 h after irradiation (24AI)) demonstrated a significantly greater reduction in microbial count (p > 0.05).
Directly after laser application, Streptococcus mutans showed a significantly greater reduction with T1 settings compared to T2, at 80.0% ± 6.1% and 41.4% ± 4.2%, respectively (p < 0.05). Furthermore, a significantly higher reduction efficiency was observed directly after laser application compared to the 24 h follow-up for both laser settings (T1 and T2) (p < 0.05) (Table 2).

3.2. Microbial CFU Reduction in Dual-Species Planktonic Cultures

The highest reduction in microbial count was observed for Candida albicans (C.a.) in the CASM mixture, at 81.5% ± 2.3% and 71.2% ± 1.8% when measured directly after irradiation (DAI) and 24 h after laser application (24AI), respectively. Moreover, the reduction measured DAI was significantly higher than at 24AI (p < 0.05). Additionally, Er:YAG laser irradiation using the T1 settings resulted in significantly greater microbial count reduction compared to the T2 settings at both time points (p < 0.05).
In contrast, S. mutans in the CASM mixture exhibited significantly greater CFU reduction 24 h after Er:YAG laser irradiation at the T1 settings, and significantly lower reduction when measured at the T2 settings (p < 0.05). Furthermore, in the CGSM mixture, Streptococcus mutans showed greater CFU reduction 24 h after the Er:YAG laser intervention (T1: 58.0% ± 19.0%; T2: 18.8% ± 3.0%) compared to directly after intervention (T1: 47.5% ± 31.8%; T2: 0.0% ± 0.0%) (p < 0.05).
Candida glabrata in the CACG mixture demonstrated significantly greater reduction at the T1 settings compared to T2, with reductions of 36.2% ± 3.0% and 3.2% ± 4.5%, respectively (p < 0.05) (Table 3).

3.3. Microbial CFU Reduction in Single-Species Biofilm Cultures

In single-species biofilms, CFU reduction ranged from 98.4% ± 1.3% for C. glabrata to 56.1% ± 8.6% for C. albicans under T2 laser parameters.
However, significant differences were observed only for C. albicans between the T1 (95.3% ± 2.8%) and T2 laser settings (56.1% ± 8.6%) (p < 0.05) (Table 4).

3.4. Microbial CFU Reduction in Dual-Species Biofilm Cultures

Higher mean reductions in %CFU were observed in dual-species biofilm cultures at higher irradiance (T2) compared to the lower settings (T1). For T2, reductions were as follows: Candida albicans (CACG: 99.9% ± 0.1%, CASM: 99.9% ± 0.1%), Candida glabrata (CACG: 98.8% ± 0.6%, CGSM: 100.0% ± 0.0%), and Streptococcus mutans (CASM: 99.9% ± 0.0%, CGSM: 100.0% ± 0.0%). For T1, reductions were as follows: Candida albicans (CACG: 99.0% ± 0.2%, CASM: 96.5% ± 0.2%), Candida glabrata (CACG: 79.9% ± 9.9%, CGSM: 39.1% ± 8.8%), and Streptococcus mutans (CASM: 96.9% ± 1.8%, CGSM: 47.3% ± 10.4%).
Significantly greater %CFU reductions were observed with T2 compared to the T1 settings for C. albicans in the CACG and CASM mixtures, C. glabrata in the CGSM mixture, and S. mutans in the CGSM mixture (p < 0.05) (Table 5).

3.5. Biofilm Biomass Reduction (Crystal Violet Assay)

In the C. albicans–S. mutans (CASM) biofilm, a significantly higher reduction in biomass was observed at the T1 settings (33.7% ± 1.1) compared to the T2 settings (4.8% ± 5.2) (p = 0.016), indicating that higher laser power (T2) was less effective in reducing biofilm biomass compared to lower power (T1). Similarly, the C. glabrata–S. mutans (CGSM) biofilm exhibited a significantly greater reduction at T1 (21.8% ± 3.1) compared to the T2 settings (2.15% ± 3.0) (p = 0.023), further suggesting decreased efficiency at higher laser power. Additionally, in the C. albicans–C. glabrata (CACG) biofilm, no statistically significant reduction was observed between the two assessed settings: T1 (16.4% ± 12.1) and T2 (0% ± 0) (p = 0.196). The ANOVA results confirmed that the overall differences between the groups were not statistically significant (p = 0.192 for T1 and p = 0.380 for T2). (Table 6)

4. Discussion

Our research underscores the critical importance of addressing yeast biofilms due to the significant interactions between Candida spp. and bacterial species, which are important in the formation and progression of biofilms and associated oral diseases. These synergistic interactions exacerbate conditions such as caries, periodontal diseases and peri-implantitis. Among the microorganisms evaluated, Candida albicans demonstrated the greatest sensitivity to biofilm reduction. The key findings demonstrated that Er:YAG laser irradiation could inhibit biofilm growth even at relatively low energy and fluence (40 mJ; 3 J/cm2), while also significantly reducing mature Candida spp. biofilms in combination with S. mutans. A reduction of 95.3% ± 2.8% in single-species biofilms and reductions between 96.5% ± 0.2% and 99.9% ± 0.1% in dual-species biofilms were achieved for this species using Er:YAG laser irradiation. A significantly greater decrease in microbial count was observed after laser irradiation, particularly 24 h post-irradiation, for both irradiance parameters (T1: 11 W/cm2 and T2: 120 W/cm2). Candida glabrata, while generally more resistant to physical and chemical treatments, showed a reduction of 98.4% ± 1.3% in single-species biofilms under the T2 settings. Conversely, in dual-species biofilms, C. glabrata demonstrated distinctive response patterns, particularly at higher irradiance settings (T2), where the reduction in microbial load was significantly lower, reaching only 3.2% ± 4.5%. These findings highlight the Er:YAG laser’s effectiveness in reducing microbial loads, particularly in biofilms containing Candida albicans and mixed-species compositions. However, the results also emphasize the importance of adjusting laser settings to the specific microbial composition within the biofilm to achieve optimal clinical outcomes.
The findings of this study indicate that lower-power Er:YAG laser settings (T1) were more effective in reducing biofilm biomass compared to the higher-power settings (T2). This observation is counterintuitive, as higher power typically correlates with greater antimicrobial effects. However, multiple factors, including heat distribution, microbial adaptive responses, and biofilm structural alterations, may explain this phenomenon.
One possible explanation for the greater biofilm reduction observed at the T1 settings is related to thermal energy dissipation. Lower power settings deliver energy more gradually, potentially causing a sustained thermal effect that destabilizes microbial cells and biofilm architecture without leading to excessive heat accumulation. In contrast, higher power settings (T2) may lead to rapid energy deposition, generating a more intense but localized heating effect. Excessive heat can induce protective mechanisms within microbial communities, including heat shock responses, which may promote cellular survival rather than eradication. Some studies have suggested that abrupt thermal stress triggers microbial adaptation strategies, leading to increased biofilm resilience and reducing overall effectiveness at higher energy settings. The architecture of mixed-species biofilms plays a crucial role in their susceptibility to laser irradiation. Er:YAG lasers primarily interact with water molecules, and their effectiveness depends on the hydration level of the biofilm matrix. Under the T1 settings, laser energy may be optimally absorbed by the biofilm water content, leading to progressive structural disruption without immediate collapse. However, under the T2 settings, rapid vaporization could result in biofilm contraction, where the surface layers shrink, limiting laser penetration into deeper biofilm regions. This effect could shield embedded microbial cells from complete eradication, explaining the reduced biofilm biomass elimination at higher power settings.
These findings emphasize the importance of adjusting laser parameters based on biofilm composition and structure. While higher laser power (T2) might be beneficial for mechanical debridement, the controlled thermal effects at lower power (T1) appear to enhance microbial reduction, particularly in Candida–Streptococcus dual-species biofilms.
Previous research by our group, reported in Grzech-Leśniak et al. [41], using Nd:YAG laser at low energy settings has demonstrated a significant reduction in pathogens, often exceeding 95% immediately after irradiation (DAI), depending on the fluence and parameters used. The Nd:YAG laser, with its 1064 nm wavelength, penetrates deeper into biofilms compared to the Er:YAG laser (2940 nm), which primarily affects surface biofilm layers due to its high absorption in water. This superior penetration depth of the Nd:YAG laser is particularly advantageous in disrupting deeper biofilm layers, where microorganisms are often more resistant to conventional treatments. A study from 2019 [42] demonstrated that high microbial reductions were achieved in single-species biofilms of Candida albicans and Streptococcus mutans using the Nd:YAG laser with low-level laser settings, underscoring its effectiveness in eliminating pathogens beyond the surface layer. By contrast, our study observed that while the Er:YAG laser was effective in reducing microbial loads, particularly for C. albicans, its efficacy was reduced in dual-species biofilms, especially those with C. glabrata, under higher irradiance settings (T2). These differences align with the findings of Grzech-Leśniak et al. (2024) [41], which emphasize the importance of laser parameter optimization to address biofilm complexity. This research builds on these insights, showing that while erbium lasers have clinical relevance, they require tailored settings for complex biofilms, where neodymium lasers may excel in certain contexts.
Er:YAG lasers, known for their photothermal and photoacoustic effects, have shown significant efficacy in biofilm disruption by targeting water molecules in the extracellular matrix and inducing cavitation. In clinical applications, these mechanisms have proven effective in disrupting biofilms through photothermal effects and cell wall disruption on tooth surfaces, root canals, peri-implant areas and other oral tissues [43,44,45,46,47,48,49]. Despite the superior depth of penetration offered by Nd:YAG lasers, Er:YAG lasers have demonstrated high efficacy in biofilm reduction, particularly in dual-species biofilms. Their ability to disrupt biofilm structures mechanically, in addition to their antimicrobial effects, makes them a valuable tool in non-surgical periodontal therapy. However, Nd:YAG lasers’ ability to reach deeper layers suggests that they may be more effective in cases where subgingival biofilms or peri-implant infections require a more extensive decontamination approach. Our findings reveal that the Er:YAG laser achieved substantial reductions in microbial counts for C. albicans, with reductions exceeding 99.9% in some dual-species biofilms, especially for C. albicans–S. mutans (CASM) and C. albicans–C. glabrata (CACG) biofilms. However, Candida glabrata exhibited notable resistance at higher irradiance levels (T2) for dual-species planktonic cultures and at lower irradiance (T1) for dual-species biofilm cultures, highlighting the species-specific nature of biofilm resilience. Comparative studies by Nagahashi et al. (2022) and Terlep et al. (2023) have demonstrated that Er:YAG lasers achieve significant biofilm reductions, particularly in constrained geometries mimicking periodontal pockets, through photoacoustic streaming and cavitation [46,47]. While these studies confirm the efficacy of Er:YAG lasers in biofilm disruption, our results underscore the need for tailored irradiance settings to address species-specific resistance patterns, particularly in complex biofilms involving multiple microorganisms [48].
CO2 lasers have also demonstrated notable dual effects in biofilm management, disrupting biofilm layers through photothermal mechanisms while inducing microbial adaptation responses, such as stress-related gene expression and DNA methylation changes [50]. Studies by Cohen et al. (2014) and Gryzińska et al. (2023) highlighted the antibacterial and antifungal potential of CO2 lasers, particularly against Candida albicans and Streptococcus mutans biofilms [50,51]. Cohen et al.’s research on CO2 laser effects demonstrated their antibacterial efficacy through photothermal mechanisms, effectively penetrating biofilm layers and altering enamel properties to improve resistance to acid attacks, suggesting their potential for caries prevention [50]. Gryzińska et al. further explored epigenetic adaptations in C. albicans, showing that physical factors such as laser exposure can increase DNA methylation levels, potentially enhancing biofilm resilience through gene regulation [51]. Compared to Er:YAG lasers, CO2 lasers offer deeper penetration, altering enamel properties to enhance resistance to acid attacks, making them promising tools for caries prevention [52,53,54]. Additionally, autofluorescence studies, such as those by Wiench et al. (2024), have demonstrated diagnostic advantages, with Candida albicans exhibiting stronger autofluorescence properties under 405 nm light compared to Candida glabrata [55]. These findings suggest that autofluorescence-guided laser therapies could enhance the precision of biofilm management strategies. Studies have demonstrated that in mixed-species biofilms, erbium lasers may provide better microbial reductions without compromising enamel or dentin integrity, as shown in research focusing on dental applications [46,56,57,58,59]. These results complement studies using Nd:YAG and Er:YAG lasers, highlighting the diagnostic and therapeutic potential for managing Candida infections.
The interaction between S. mutans and Candida spp. increases resistance to conventional treatments, emphasizing the need for laser-based therapies that penetrate biofilm layers effectively. In the current study, Streptococcus mutans in single-species planktonic cultures exhibited an 80.0% ± 6.1% (p < 0.05) reduction immediately after laser irradiation, even with low power settings. However, in dual-species cultures involving C. albicans or C. glabrata, higher irradiance and a longer duration (24 h) were required to achieve substantial CFU reductions (99.0% to 100.0%, p < 0.05). According to the National Committee for Clinical Laboratory Standards (NCCLS) guidelines, an antimicrobial treatment achieves ≥ 3 log₁₀ CFU/mL reduction, equivalent to a 99.9% reduction. In this study, certain conditions resulted in microbial reductions exceeding 99.9%, suggesting potential bactericidal/fungicidal activity. However, there were cases where reductions were lower, highlighting the need for further optimization of laser parameters to enhance antimicrobial efficacy [60]. These findings align with previous studies using Nd:YAG lasers, where better reductions in C. glabrata were achieved immediately after irradiation (DAI), contrasting with Er:YAG lasers, which required more time and higher parameters [41]. In this study, C. glabrata showed significant reductions only under the T1 settings (36.2% ± 3.0%) and markedly lower reductions under the T2 settings (3.2% ± 4.5%). These results underscore the importance of tailoring laser parameters and integrating advanced imaging techniques to optimize biofilm management and enhance clinical relevance. Together, these methodologies highlight the importance of tailoring experimental designs to the research context, balancing simplicity with providing translational value for clinical use [61,62,63]. Our findings indicate that lower laser power (T1) was more effective in reducing biofilm biomass compared to higher power (T2). This observation aligns with studies utilizing the Er:YAG laser, which has demonstrated significant efficacy in biofilm removal. For instance, Polak et al. found that the Er:YAG laser effectively removed multispecies biofilms from titanium surfaces, outperforming traditional methods such as hand curettes and ultrasonic devices, even at low energy settings [64]. Additionally, studies have reported enhanced bacterial and lipopolysaccharide clearance, as well as improved human gingival fibroblast adhesion, on titanium and zirconia disc surfaces [65,66,67]. Similarly, AlMoharib et al. reported that Er:YAG laser treatment significantly reduced the bacterial biofilm on titanium discs, achieving comparable results to mechanical debridement tools like titanium brushes and carbon fiber curettes [68]. These studies suggest that Er:YAG lasers are effective in biofilm removal at lower energy settings, supporting our findings that higher laser power does not necessarily enhance biofilm reduction and may even be less effective.
Despite the promising findings, this study has certain limitations. The in vitro nature of the experiments, using controlled biofilm models, may not fully replicate clinical conditions, where factors such as saliva flow, immune responses and biofilm complexity are more pronounced. Additionally, the observed resistance patterns of Candida glabrata at higher irradiance levels underscore the need for further research to understand the underlying mechanisms and to optimize laser parameters for species-specific efficacy. Another limitation of this study is the low number of replications, which may impact the reproducibility of the findings and necessitate further validation through larger-scale studies. Future studies should explore the integration of advanced imaging techniques, such as autofluorescence-guided therapies (an innovative diagnostic approach) and scanning electron microscopy (SEM) imaging, to assess biofilm structure and surface modifications after laser treatment and investigate the combined use of lasers with photosensitizers to enhance treatment outcomes. Incorporating metabolic assays and in vivo models could provide deeper insights into the effects of laser irradiation on biofilm dynamics. Furthermore, expanding research to include diverse biofilm compositions and clinical scenarios will help validate the translational value of these findings, ultimately contributing to improved protocols for managing biofilm-associated infections.

5. Conclusions

The findings demonstrate that laser settings and time points have a significant impact on microbial reduction in both Candida spp. biofilms and planktonic cultures, depending on the microorganism and experimental conditions. Higher laser settings (T2) generally resulted in greater CFU reductions, particularly in double-species biofilms. However, certain species like C. glabrata and S. mutans exhibited unique responses, depending on the laser settings and assessment time, highlighting the importance of tailored approaches for biofilm management.

Author Contributions

Conceptualization, K.G.-L., J.M. and Z.G.-L.; methodology, K.G.-L., J.N. and M.P.; software, K.G.-L., J.M. and Z.G.-L.; validation, K.G.-L., J.M., Z.G.-L., J.N. and M.P.; formal analysis, K.G.-L., Z.G.-L., R.W., J.N. and M.P.; investigation, Z.G.-L., J.P., J.S., P.K., M.P. and J.N.; resources, K.G.-L. and Z.G.-L.; data curation, Z.G.-L., J.N. and M.P.; writing—original draft preparation, Z.G.-L. and K.G.-L.; writing—review and editing, Z.G.-L., K.G.-L., R.W., M.D. and J.M.; visualization, Z.G.-L. and J.P.; supervision, K.G.-L., M.D. and J.M.; project administration, Z.G.-L., K.G.-L. and J.M.; funding acquisition, K.G.-L. and Z.G.-L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Wroclaw Medical University through laser-related curriculum funding for students (ZR 2023-149.11).

Institutional Review Board Statement

This study was approved by the Bioethics Committee of Wroclaw Medical University (KB-429, on 27 June 2024).

Informed Consent Statement

Patient consent was waived because the samples were provided to the university by the Museum of the Department of Microbiology, and patients’ consent for using these samples in research had previously been obtained by the providing institution.

Data Availability Statement

Data are contained within the article.

Acknowledgments

During the preparation of this work, the authors used ChatGPT4.0 to improve readability and language. After using this tool/service, the authors reviewed and edited the content as needed, and they take full responsibility for the content of the publication.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Koo, H.; Andes, D.R.; Krysan, D.J. Candida-streptococcal interactions in biofilm-associated oral diseases. PLoS Pathog. 2018, 14, e1007342. [Google Scholar] [CrossRef] [PubMed]
  2. Abrantes, P.M.D.S.; Africa, C.W.J. Measuring Streptococcus mutans, Streptococcus sanguinis and Candida albicans biofilm formation using a real-time impedance-based system. J. Microbiol. Methods. 2020, 169, 105815. [Google Scholar] [CrossRef]
  3. O’Donnell, L.E.; Millhouse, E.; Sherry, L.; Kean, R.; Malcolm, J.; Nile, C.J.; Ramage, G. Polymicrobial Candida biofilms: Friends and foe in the oral cavity. FEMS Yeast Res. 2015, 15, fov077. [Google Scholar] [CrossRef]
  4. Allison, D.L.; Willems, H.M.E.; Jayatilake, J.A.M.S.; Bruno, V.M.; Peters, B.M.; Shirtliff, M.E. Candida-Bacteria Interactions: Their Impact on Human Disease. Microbiol. Spectr. 2016, 4, 103–136. [Google Scholar] [CrossRef]
  5. Desai, J.P.; Nair, R.U. Oral Health Factors Related to Rapid Oral Health Deterioration among Older Adults: A Narrative Review. J. Clin. Med. 2023, 12, 3202. [Google Scholar] [CrossRef]
  6. Lafuente-Ibáñez de Mendoza, I.; Cayero-Garay, A.; Quindós-Andrés, G.; Aguirre-Urizar, J.M. A systematic review on the implication of Candida in peri-implantitis. Int. J. Implant. Dent. 2021, 7, 73. [Google Scholar] [CrossRef] [PubMed]
  7. Wint, W.Y.; Miyanohara, M.; Terada-Ito, C.; Yamada, H.; Ryo, K.; Murata, T. Effects of Sucrose and Farnesol on Biofilm Formation by Streptococcus mutans and Candida albicans. Microorganisms 2024, 12, 1737. [Google Scholar] [CrossRef] [PubMed]
  8. Contaldo, M.; Romano, A.; Mascitti, M.; Fiori, F.; Della Vella, F.; Serpico, R.; Santarelli, A. Association between denture stomatitis, candida species and diabetic status. J. Biol. Regul. Homeost. Agents 2019, 33 (Suppl. S1), 35–41. [Google Scholar]
  9. Pokrowiecki, R.; Mielczarek, A.; Zaręba, T.; Tyski, S. Oral microbiome and peri-implant diseases: Where are we now? Ther. Clin. Risk Manag. 2017, 13, 1529–1542. [Google Scholar] [CrossRef]
  10. El Mobadder, M.; Nammour, S.; Grzech-Leśniak, Z.; Grzech-Leśniak, K. Efficacy of the Adjunct Use of Povidone-Iodine or Sodium Hypochlorite with Non-Surgical Management of Periodontitis: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 6593. [Google Scholar] [CrossRef]
  11. Afrasiabi, S.; Benedicenti, S.; Signore, A.; Arshad, M.; Chiniforush, N. Simultaneous Dual-Wavelength Laser Irradiation against Implant-Adherent Biofilms of Staphylococcus aureus, Escherichia coli, and Candida albicans for Improved Antimicrobial Photodynamic Therapy. Bioengineering 2024, 11, 48. [Google Scholar] [CrossRef] [PubMed]
  12. Tavares, L.J.; Pavarina, A.C.; Vergani, C.E.; de Avila, E.D. The impact of antimicrobial photodynamic therapy on peri-implant disease: What mechanisms are involved in this novel treatment? Photodiagnosis Photodyn. Ther. 2017, 17, 236–244. [Google Scholar] [CrossRef]
  13. El Mobadder, M.; Grzech-Lesniak, Z.; El Mobadder, W.; Rifai, M.; Ghandour, M.; Nammour, S. Management of Medication-Related Osteonecrosis of the Jaw with Photobiomodulation and Minimal Surgical Intervention. Dent. J. 2023, 11, 127. [Google Scholar] [CrossRef] [PubMed]
  14. Ali, D.; Alsalman, J. Efficacy of mechanical debridement with adjunct antimicrobial photodynamic therapy against peri-implant subgingival oral yeasts colonization: A systematic review and meta-analysis. Photodiagnosis Photodyn. Ther. 2024, 50, 104399. [Google Scholar] [CrossRef] [PubMed]
  15. Almeslet, A.S.; ALOsaimi, M.M.; Jhugroo, C.; Alshammari, A.F.; Divakar, D.D.; Soman, C. Efficacy of non-surgical mechanical debridement with and without adjunct antimicrobial photodynamic therapy in the treatment of peri-implantitis among patients undergoing chemotherapy. Photodiagnosis Photodyn. Ther. 2025, 52, 104476. [Google Scholar] [CrossRef]
  16. Shetty, B.; Ali, D.; Ahmed, S.; Ibraheem, W.I.; Preethanath, R.S.; Vellappally, S.; Divakar, D.D. Role of antimicrobial photodynamic therapy in reducing subgingival oral yeasts colonization in patients with peri-implant mucositis. Photodiagnosis Photodyn. Ther. 2022, 38, 102803. [Google Scholar] [CrossRef]
  17. Malik, N.K.A.; Alkadhi, O.H. Effectiveness of mechanical debridement with and without antimicrobial photodynamic therapy against oral yeasts in children with gingivitis undergoing fixed orthodontic therapy. Photodiagnosis Photodyn. Ther. 2020, 31, 101768. [Google Scholar] [CrossRef]
  18. Rocha, A.R.; Inada, N.M.; da Silva, A.P.; Bagnato, V.S.; Buzzá, H.H. Photodynamic inactivation strategies for maximizing antifungal effect against Sporothrix spp. and Candida albicans in an in vitro investigation. PLoS Negl. Trop. Dis. 2024, 18, e0012637. [Google Scholar] [CrossRef]
  19. Deeb, J.G.; Grzech-Leśniak, K.; Weaver, C.; Matys, J.; Bencharit, S. Retrieval of Glass Fiber Post Using Er:YAG Laser and Conventional Endodontic Ultrasonic Method: An In Vitro Study. J. Prosthodont. 2019, 28, 1024–1028. [Google Scholar] [CrossRef]
  20. Elkharashi, A.; Grzech-Leśniak, K.; Deeb, J.G.; Abdulmajeed, A.A.; Bencharit, S. Exploring the use of pulsed erbium lasers to retrieve a zirconia crown from a zirconia implant abutment. PLoS ONE 2020, 15, e0233536. [Google Scholar] [CrossRef]
  21. Deeb, J.G.; Skrjanc, L.; Kanduti, D.; Carrico, C.; Saturno, A.M.; Grzech-Leśniak, K. Evaluation of Er:YAG and Er,Cr:YSGG laser irradiation for the debonding of prefabricated zirconia crowns. Adv. Clin. Exp. Med. 2021, 30, 7–15. [Google Scholar] [CrossRef] [PubMed]
  22. da Costa Ribeiro, C.E.V.; Lena, I.M.; Santi, S.S.; Malta, C.P.; Zanatta, F.B.; Morgental, R.D. Effects of laser treatment on bond strength of epoxy resin and calcium silicate-based sealers: A systematic review and meta-analysis of in vitro studies. Clin. Oral. Investig. 2024, 28, 644. [Google Scholar] [CrossRef] [PubMed]
  23. Gufran, K.; Alqahtani, A.S.; Alasqah, M.; Alsakr, A.; Alkharaan, H.; Ghurmallah Alzahrani, H.; Almutairi, A. Effect of Er: YAG laser therapy in non-surgical periodontal treatment: An umbrella review. BMC Oral. Health 2024, 24, 1347. [Google Scholar] [CrossRef]
  24. Jafari Semnani, S.; Moghadam, K.N.; Jafari, Z.; Chiniforush, N. Comparative effects of the conventional, ultrasonic, and laser-activated irrigation on penetration depth of three photosensitizers in the root canal system. Photodiagnosis Photodyn. Ther. 2024, 49, 104286. [Google Scholar] [CrossRef]
  25. Xu, P.; Ren, C.; Jiang, Y.; Yan, J.; Wu, M. Clinical application of Er:YAG laser and traditional dental turbine in caries removal in children. J. Clin. Pediatr. Dent. 2024, 48, 183–188. [Google Scholar] [CrossRef] [PubMed]
  26. Yoshida, R.; Kobayashi, K.; Onuma, K.; Yamamoto, R.; Chiba Ohkuma, R.; Karakida, T.; Yamakawa, S.; Hosoya, N.; Yamazaki, Y.; Yamakoshi, Y. Enhancement of Differentiation and Mineralization of Human Dental Pulp Stem Cells via TGF-β Signaling in Low-Level Laser Therapy Using Er:YAG Lasers. J. Oral. Biosci. 2025, 18, 100617. [Google Scholar] [CrossRef]
  27. Grzech-Leśniak, K.; Matys, J. The Effect of Er:YAG Lasers on the Reduction of Aerosol Formation for Dental Workers. Materials 2021, 14, 2857. [Google Scholar] [CrossRef]
  28. Kurtzman, G.M.; Horowitz, R.A.; Johnson, R.; Prestiano, R.A.; Klein, B.I. The systemic oral health connection: Biofilms. Medicine 2022, 101, e30517. [Google Scholar] [CrossRef]
  29. Das, A.; Patro, S.; Simnani, F.Z.; Singh, D.; Sinha, A.; Kumari, K.; Rao, P.V.; Singh, S.; Kaushik, N.K.; Panda, P.K.; et al. Biofilm modifiers: The disparity in paradigm of oral biofilm ecosystem. Biomed. Pharmacother. 2023, 164, 114966. [Google Scholar] [CrossRef]
  30. Czarnowski, M.; Słowińska, M.; Sawieljew, M.; Wnorowska, U.; Daniluk, T.; Król, G.; Karasiński, M.; Okła, S.; Savage, P.B.; Piktel, E.; et al. Efficacy of Ceragenins in Controlling the Growth of Oral Microorganisms: Implications for Oral Hygiene Management. Pharmaceuticals 2024, 17, 204. [Google Scholar] [CrossRef]
  31. Tian, S.; Ding, T.; Li, H. Oral microbiome in human health and diseases. Life 2024, 3, 367–383. [Google Scholar] [CrossRef] [PubMed]
  32. Do, Q.L.; Gaudin, A. The Efficiency of the Er: YAG Laser and PhotonInduced Photoacoustic Streaming (PIPS) as an Activation Method in Endodontic Irrigation: A Literature Review. J. Lasers Med. Sci. 2020, 11, 316–334. [Google Scholar] [CrossRef] [PubMed]
  33. Lukač, N.; Jezeršek, M. Amplification of pressure waves in laser-assisted endodontics with synchronized delivery of Er:YAG laser pulses. Lasers Med. Sci. 2018, 33, 823–833. [Google Scholar] [CrossRef] [PubMed]
  34. Hill, R.A.; Stern, D.; Lesiecki, M.L.; Hsia, J.; Berns, M.W. Effects of pulse width on erbium:YAG laser photothermal trabecular ablation (LTA). Lasers Surg. Med. 1993, 13, 440–446. [Google Scholar] [CrossRef]
  35. Zhao, A.; Sun, J.; Liu, Y. Understanding bacterial biofilms: From definition to treatment strategies. Front. Cell Infect. Microbiol. 2023, 13, 1137947. [Google Scholar] [CrossRef]
  36. Matys, J.; Grzech-Leśniak, K.; Flieger, R.; Dominiak, M. Assessment of an Impact of a Diode Laser Mode with Wavelength of 980 nm on a Temperature Rise Measured by Means of k-02 Thermocouple: Preliminary Results. Dent. Med. Probl. 2016, 53, 345–351. [Google Scholar] [CrossRef]
  37. Reddy, N.; Golob Deeb, J.; Kitten, T.; Carrico, C.K.; Grzech-Leśniak, K. The In Vitro Effect of Laser Irradiation (Er:YAG and CO2) and Chemical Reagents (Hydrogen Peroxide, Sodium Hypochlorite, Chlorhexidine, or Sodium Fluoride) Alone or in Combination on Reducing Root Caries Bacteria. Int. J. Mol. Sci. 2022, 23, 15732. [Google Scholar] [CrossRef]
  38. Golob Deeb, J.; Smith, J.; Belvin, B.R.; Lewis, J.; Grzech-Leśniak, K. Er:YAG Laser Irradiation Reduces Microbial Viability When Used in Combination with Irrigation with Sodium Hypochlorite, Chlorhexidine, and Hydrogen Peroxide. Microorganisms 2019, 7, 612. [Google Scholar] [CrossRef]
  39. Yao, W.; Kuan, E.C.; Francis, N.C.; St John, M.A.; Grundfest, W.S.; Taylor, Z.D. Laser-generated shockwaves enhance antibacterial activity against biofilms in vitro. Lasers Surg. Med. 2017, 49, 539–547. [Google Scholar] [CrossRef]
  40. Mamone, L.; Tomás, R.; Di Venosa, G.; Gándara, L.; Durantini, E.; Buzzola, F.; Casas, A. Laser NIR Irradiation Enhances Antimicrobial Photodynamic Inactivation of Biofilms of Staphylococcus aureus. Lasers Surg. Med. 2024, 56, 783–795. [Google Scholar] [CrossRef]
  41. Grzech-Leśniak, Z.; Szwach, J.; Lelonkiewicz, M.; Migas, K.; Pyrkosz, J.; Szwajkowski, M.; Kosidło, P.; Pajączkowska, M.; Wiench, R.; Matys, J.; et al. Effect of Nd:YAG Laser Irradiation on the Growth of Oral Biofilm. Microorganisms 2024, 12, 2231. [Google Scholar] [CrossRef]
  42. Grzech-Leśniak, K.; Nowicka, J.; Pajączkowska, M.; Matys, J.; Szymonowicz, M.; Kuropka, P.; Rybak, Z.; Dobrzyński, M.; Dominiak, M. Effects of Nd:YAG laser irradiation on the growth of Candida albicans and Streptococcus mutans: In vitro study. Lasers Med. Sci. 2019, 34, 129–137. [Google Scholar] [CrossRef] [PubMed]
  43. Han, S.Y.; Jung, H.I.; Kwon, H.K.; Kim, B.I. Combined effects of Er:YAG laser and nano-carbonate apatite dentifrice on dentinal tubule occlusion: In vitro study. Photomed. Laser Surg. 2013, 31, 342–348. [Google Scholar] [CrossRef] [PubMed]
  44. Volk, M.; Molan, K.; Šavli, D.; Terlep, S.; Levičnik-Höfferle, Š.; Gašpirc, B.; Lukač, M.; Jezeršek, M.; Stopar, D. Biofilm removal from Difficult-to-Reach places via secondary cavitation within a constrained geometry mimicking a Periodontal/Peri-Implant pocket. Ultrason. Sonochem. 2024, 104, 106832. [Google Scholar] [CrossRef]
  45. Meire, M.A.; Coenye, T.; Nelis, H.J.; De Moor, R.J. In vitro inactivation of endodontic pathogens with Nd:YAG and Er:YAG lasers. Lasers Med. Sci. 2012, 27, 695–701. [Google Scholar] [CrossRef] [PubMed]
  46. Nagahashi, T.; Yahata, Y.; Handa, K.; Nakano, M.; Suzuki, S.; Kakiuchi, Y.; Tanaka, T.; Kanehira, M.; Suresh Venkataiah, V.; Saito, M. Er:YAG laser-induced cavitation can activate irrigation for the removal of intraradicular biofilm. Sci. Rep. 2022, 12, 4897. [Google Scholar] [CrossRef]
  47. Terlep, S.; Dogsa, I.; Pajk, F.; Stopar, D. Biofilm Removal from In Vitro Narrow Geometries Using Single and Dual Pulse Er:YAG Laser Photoacoustic Irrigation. Microorganisms 2023, 11, 2102. [Google Scholar] [CrossRef]
  48. Meire, M.; De Moor, R.J.G. Principle and antimicrobial efficacy of laser-activated irrigation: A narrative review. Int. Endod. J. 2024, 57, 841–860. [Google Scholar] [CrossRef]
  49. Golob Deeb, J.; Reddy, N.; Kitten, T.; Carrico, C.K.; Grzech-Leśniak, K. Viability of Bacteria Associated with Root Caries after Nd:YAG Laser Application in Combination with Various Antimicrobial Agents: An In Vitro Study. Dent. Med. Probl. 2023, 60, 649–655. [Google Scholar] [CrossRef]
  50. Cohen, J.; Featherstone, J.D.; Le, C.Q.; Steinberg, D.; Feuerstein, O. Effects of CO2 laser irradiation on tooth enamel coated with biofilm. Lasers Surg. Med. 2014, 46, 216–223. [Google Scholar] [CrossRef]
  51. Gryzinska, M.; Kot, B.; Dudzinska, E.; Biernasiuk, A.; Jakubczak, A.; Malm, A.; Andraszek, K. Changes in the Level of DNA Methylation in Candida albicans under the Influence of Physical and Chemical Factors. Int. J. Mol. Sci. 2023, 24, 15873. [Google Scholar] [CrossRef] [PubMed]
  52. Rechmann, P.; Rechmann, B.M.; Groves, W.H., Jr.; Le, C.Q.; Rapozo-Hilo, M.L.; Kinsel, R.; Featherstone, J.D. Caries inhibition with a CO2 9.3 μm laser: An in vitro study. Lasers Surg. Med. 2016, 48, 546–554. [Google Scholar] [CrossRef] [PubMed]
  53. Featherstone, J.D.; Barrett-Vespone, N.A.; Fried, D.; Kantorowitz, Z.; Seka, W. CO2 laser inhibitor of artificial caries-like lesion progression in dental enamel. J. Dent. Res. 1998, 77, 1397–1403. [Google Scholar] [CrossRef]
  54. Feng, Z.; Yuan, R.; Cheng, L.; Fan, H.; Si, M.; Hao, Z. Effect of Er:YAG Laser Irradiation on Preventing Enamel Caries: A Systematic Review and Meta-Analysis. Int. Dent. J. 2024, 74, 679–687. [Google Scholar] [CrossRef] [PubMed]
  55. Wiench, R.; Paliga, D.; Mertas, A.; Bobela, E.; Kuśka-Kiełbratowska, A.; Bordin-Aykroyd, S.; Kawczyk-Krupka, A.; Grzech-Leśniak, K.; Lukomska-Szymanska, M.; Lynch, E.; et al. Red/Orange Autofluorescence in Selected Candida Strains Exposed to 405 nm Laser Light. Dent. J. 2024, 12, 48. [Google Scholar] [CrossRef]
  56. Valenti, C.; Pagano, S.; Bozza, S.; Ciurnella, E.; Lomurno, G.; Capobianco, B.; Coniglio, M.; Cianetti, S.; Marinucci, L. Use of the Er:YAG Laser in Conservative Dentistry: Evaluation of the Microbial Population in Carious Lesions. Materials 2021, 14, 2387. [Google Scholar] [CrossRef]
  57. Asnaashari, M.; Safavi, N. Disinfection of Contaminated Canals by Different Laser Wavelengths, while Performing Root Canal Therapy. J. Lasers Med. Sci. 2013, 4, 8–16. [Google Scholar]
  58. Misischia, W.P.; Xenoudi, P.; Yukna, R.A.; Schurr, M.J. Correction to: Bacterial reduction effect of four different dental lasers on titanium surfaces in vitro. Lasers Med. Sci. 2021, 36, 1769, Erratum in Lasers Med. Sci. 2021, 36, 1759–1767. [Google Scholar] [CrossRef]
  59. Aoki, A.; Mizutani, K.; Schwarz, F.; Sculean, A.; Yukna, R.A.; Takasaki, A.A.; Romanos, G.E.; Taniguchi, Y.; Sasaki, K.M.; Zeredo, J.L.; et al. Periodontal and peri-implant wound healing following laser therapy. Periodontol. 2000 2015, 68, 217–269. [Google Scholar] [CrossRef]
  60. Barry, A.L.; Craig, W.A.; Nadler, H.; Reller, L.B.; Sanders, C.C.; Swenson, J.M. Methods for Determining Bactericidial Acivity of Antimicrobial Agents: Approved Guidelines, NCCLS Document M26-A12; Clinical and Laboratory Standards Institute: Berwyn, PA, USA, 1999; Volume 19, Available online: https://clsi.org/media/1462/m26a_sample.pdf (accessed on September 1999).
  61. Bjarnsholt, T.; Alhede, M.; Alhede, M.; Eickhardt-Sørensen, S.R.; Moser, C.; Kühl, M.; Jensen, P.Ø.; Høiby, N. The in vivo biofilm. Trends Microbiol. 2013, 21, 466–474. [Google Scholar] [CrossRef]
  62. Coenye, T.; Nelis, H.J. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 2010, 83, 89–105. [Google Scholar] [CrossRef] [PubMed]
  63. Young, T.; Alshanta, O.A.; Kean, R.; Bradshaw, D.; Pratten, J.; Williams, C.; Woodall, C.; Ramage, G.; Brown, J.L. Candida albicans as an Essential “Keystone” Component within Polymicrobial Oral Biofilm Models? Microorganisms 2020, 9, 59. [Google Scholar] [CrossRef] [PubMed]
  64. Polak, D.; Shani-Kdoshim, S.; Alias, M.; Shapira, L.; Stabholz, A. The In Vitro Efficacy of Biofilm Removal from Titanium Surfaces Using Er:YAG Laser: Comparison of Treatment Protocols and Ablation Parameters. J. Periodontol. 2022, 93, 100–109. [Google Scholar] [CrossRef] [PubMed]
  65. Wang, C.Y.; Lee, B.S.; Jhang, Y.T.; Ma, K.S.; Huang, C.P.; Fu, K.L.; Lai, C.H.; Tseng, W.Y.; Kuo, M.Y.; Chen, Y.W. Er:YAG laser irradiation enhances bacterial and lipopolysaccharide clearance and human gingival fibroblast adhesion on titanium discs. Sci. Rep. 2021, 11, 23954. [Google Scholar] [CrossRef]
  66. Huang, P.; Chen, X.; Chen, Z.; Chen, M.; He, J.; Peng, L. Efficacy of Er:YAG laser irradiation for decontamination and its effect on biocompatibility of different titanium surfaces. BMC Oral. Health 2021, 21, 649. [Google Scholar] [CrossRef]
  67. Assery, N.; Alomeir, N.; Zeng, Y.; Xiao, J.; Tsigarida, A. The effect of Er:YAG laser treatment on biofilm formation on titanium and zirconia disc surfaces. J. Periodontol. 2023, 94, 344–353. [Google Scholar] [CrossRef]
  68. AlMoharib, H.S.; Steffensen, B.; Zoukhri, D.; Finkelman, M.; Gyurko, R. The efficacy of Er:YAG laser in biofilm removal from titanium surfaces: An in vitro study. J. Periodontol. 2021, 92, 593–600. [Google Scholar] [CrossRef]
Figure 1. Diagram illustrating the methodology for erbium laser irradiation with H14 dental handpiece and cylindric tip of planktonic cell solutions and biofilms.
Figure 1. Diagram illustrating the methodology for erbium laser irradiation with H14 dental handpiece and cylindric tip of planktonic cell solutions and biofilms.
Life 15 00474 g001
Table 1. Control and test groups with the laser parameters used in this study.
Table 1. Control and test groups with the laser parameters used in this study.
Control GroupTest Group (T1)Test Group (T2)
No laser irradiationPower: 0.15 WPower: 1.6 W
Frequency: 2 HzFrequency: 40 Hz
Tip diameter: 1.3 mmTip diameter: 1.3 mm
Irradiation time: 30 sIrradiation time: 30 s
Pulse duration: 300 µsPulse duration: 300 µs
Energy: 75 mJEnergy: 40 mJ
Fluence: 5.65 J/cm2Fluence: 3.01 J/cm2
Irradiance: 11.3 W/cm2Irradiance: 120.54 W/cm2
Table 2. Percentage reduction in CFU/mL for all single-species planktonic cultures.
Table 2. Percentage reduction in CFU/mL for all single-species planktonic cultures.
MicroorganismTimeHandpieceMean %CFU Reduction (SD)p-Value
T1 vs. T2
T1T2
Candida albicans (C.a.)DAIH1458.4% (±3.9%)60.9% (±12.2)0.804
24AI69.2% (±2.0)79.4% (±11.5)0.340
p-value
DAI vs. 24AI
0.0720.258x
Candida glabrata (C.g.)DAIH1477.1% (±6.2)62.2% (±4.8)0.116
24AI92.6% (±4.2)88.5% (±4.7)0.454
p-value
DAI vs. 24AI
0.1010.032x
Streptococcus mutans
(S.m.)
DAIH1480.0% (±6.1)41.4% (±4.2)0.018
24AI0.0% (±0.0)0.0% (±0.0)0.293
p-value
DAI vs. 24AI
0.0030.005x
DAI—directly after irradiation, 24AI—24 h after irradiation, T1—lower power, T2—higher power, C.a.—Candida albicans, C.g.—Candida glabrata, S.m.—Streptococcus mutans, %CFU—percentage reduction in the number of colony-forming units (CFUs), SD—standard deviation.
Table 3. Percentage reduction in CFU/mL for dual-species planktonic cultures.
Table 3. Percentage reduction in CFU/mL for dual-species planktonic cultures.
MicroorganismsMixtureTimeHandpieceMean %CFU Reduction (SD)p-Value
T1 vs. T2
T1T2
Candida albicans (C.a.)CACGDAIH148.7% (±12.2%)8.4% (±11.8%)0.982
24AI26.3% (±14.4%)55.1% (±21.3%)0.254
p-value
DAI vs. 24AI
0.3180.113x
CASMDAIH1481.5% (±2.3%)29.9% (±14.4%)0.037
24AI71.2% (±1.8%)10.0% (±14.1%)0.026
p-value
DAI vs. 24AI
0.0400.296x
Candida glabrata (C.g.)CGCADAIH1433.0% (±21.1%)19.6% (±17.5%)0.559
24AI36.2% (±3.0%)3.2% (±4.5%)0.013
p-value
DAI vs. 24AI
0.8510.327x
CGSMDAIH1418.1% (±1.9%)10.8% (±13.0%)0.517
24AI66.3% (±16.3%)34.7% (±11.5%)0.155
p-value
DAI vs. 24AI
0.0540.192x
Streptococcus mutans (S.m.)CASMDAIH140.0% (±0.0%)44.2% (±2.6%)0.002
24AI20.0% (±1.6%)1.7% (±2.3%)0.012
p-value
DAI vs. 24AI
0.0030.003x
CGSMDAIH1447.5% (±31.8%)0.0% (±0.0%)0.169
24AI58.0% (±19.0%)18.8% (±3.0%)0.103
p-value
DAI vs. 24AI
0.0330.012x
DAI—directly after irradiation; 24AI—24 h after irradiation; T1—lower laser power; T2—higher laser power; C.a.—Candida albicans; C.g.—Candida glabrata; S.m.—Streptococcus mutans; CACG—mixture of C. albicans + C. glabrata; CASM—mixture of C. albicans + S. mutans; CGSM—mixture of C. glabrata + S. mutans; %CFU—percentage reduction in the number of colony-forming units (CFU); SD—standard deviation.
Table 4. Summary of CFU/mL reduction in single-species biofilms.
Table 4. Summary of CFU/mL reduction in single-species biofilms.
MicroorganismsTimeHandpieceMean CFU Reduction % (SD)p-Value
T1 vs. T2
T1T2
Candida albicans (C.a.)DAIH1495.3% (±2.8%)56.1% (±8.6%)0.026
Candida glabrata (C.g.)DAIH1465.5% (±25.6%)98.4% (±1.3%)0.212
Streptococcus mutans (S.m.)DAIH1480.4% (±21.9%)96.1% (±5.3%)0.430
DAI—directly after irradiation at 24 h of growth, T1—lower power, T2—higher power, C.a.—Candida albicans, C.g.—Candida glabrata, S.m.—Streptococcus mutans, %CFU—percentage reduction in the number of colony-forming units (CFUs), SD—standard deviation.
Table 5. Summary of CFU reduction in dual-species biofilm cultures.
Table 5. Summary of CFU reduction in dual-species biofilm cultures.
MicroorganismsMixtureTimeHandpieceMean Reduction in %CFU (SD)p-Value
T1 vs. T2
T1T2
Candida albicans (C.a.)CACGDAIH1499.0% (±0.2%)99.9% (±0.1%)0.030
CASMDAIH1496.5% (±0.2%)99.9% (±0.1%)0.002
Candida glabrata (C.g.)CACGDAIH1479.9% (±9.9%)98.8% (±0.6%)0.114
CGSMDAIH1439.1% (±8.8%)100.0% (±0.0%)0.010
Streptococcus mutans (S.m.)CASMDAIH1496.9% (±1.8%)99.9% (±0.0%)0.147
CGSMDAIH1447.3% (±10.4%)100.0% (±0.0%)0.019
DAI—directly after irradiation at 24 h of growth; T1—lower-power laser setting; T2—higher-power laser setting; C.a.—Candida albicans; C.g.—Candida glabrata; S.m.—Streptococcus mutans; CACG—mixture of C. albicans + C. glabrata; CASM—mixture of C. albicans + S. mutans; CGSM—mixture of C. glabrata + S. mutans; %CFU—percentage reduction in the number of colony-forming units (CFUs); SD—standard deviation.
Table 6. Percentage biomass reduction using the crystal violet method 6.9 (3.7) 11.0 (1.9) 0(0).
Table 6. Percentage biomass reduction using the crystal violet method 6.9 (3.7) 11.0 (1.9) 0(0).
Mixture of MicroorganismsReduction Biomass in %T1 vs. T2
p-Value
T1 (SD)T2 (SD)
CASM33.7 (1.1)4.8 (5.2)p = 0.016
CGSM21.8 (3.1)2.15 (3.0)p = 0.023
CACG16.4 (12.1)0 (0)p = 0.196
ANOVA:p = 0.192p = 0.438×
SD—standard deviation; CASM—C. albicans + S. mutans; CGSM—C. glabrata + S. mutans; CACG—C. albicans + C. glabrata.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Grzech-Leśniak, Z.; Pyrkosz, J.; Szwach, J.; Kosidło, P.; Matys, J.; Wiench, R.; Pajączkowska, M.; Nowicka, J.; Dominiak, M.; Grzech-Leśniak, K. Antibacterial Effects of Er:YAG Laser Irradiation on Candida–Streptococcal Biofilms. Life 2025, 15, 474. https://doi.org/10.3390/life15030474

AMA Style

Grzech-Leśniak Z, Pyrkosz J, Szwach J, Kosidło P, Matys J, Wiench R, Pajączkowska M, Nowicka J, Dominiak M, Grzech-Leśniak K. Antibacterial Effects of Er:YAG Laser Irradiation on Candida–Streptococcal Biofilms. Life. 2025; 15(3):474. https://doi.org/10.3390/life15030474

Chicago/Turabian Style

Grzech-Leśniak, Zuzanna, Jakub Pyrkosz, Jagoda Szwach, Patrycja Kosidło, Jacek Matys, Rafał Wiench, Magdalena Pajączkowska, Joanna Nowicka, Marzena Dominiak, and Kinga Grzech-Leśniak. 2025. "Antibacterial Effects of Er:YAG Laser Irradiation on Candida–Streptococcal Biofilms" Life 15, no. 3: 474. https://doi.org/10.3390/life15030474

APA Style

Grzech-Leśniak, Z., Pyrkosz, J., Szwach, J., Kosidło, P., Matys, J., Wiench, R., Pajączkowska, M., Nowicka, J., Dominiak, M., & Grzech-Leśniak, K. (2025). Antibacterial Effects of Er:YAG Laser Irradiation on Candida–Streptococcal Biofilms. Life, 15(3), 474. https://doi.org/10.3390/life15030474

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop